|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/00 | |
| A61K 38/17 | |||
| A61K 39/395 | |||
| A61P 35/00 |
| (11) | Patento numeris | 2601961 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12196314.4 |
| Europos patento paraiškos padavimo data | 2008-10-03 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-06-12 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-11-28 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 07291214 | 2007-10-05 | EP |
| (72) |
Triebel, Frédéric, FR
|
| (73) |
Immutep,
Parc Club Orsay 2, Rue Jean Rostand, 91400 Orsay,
FR
|
| (54) | Compositions comprising LAG-3 and therapeutic antibodies and their uses in the treatment of cancer |
| Compositions comprising LAG-3 and therapeutic antibodies and their uses in the treatment of cancer |